{"schema_version":"secwatch.filing_event.v1","accession":"0001799191-24-000028","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.671891+00:00","generated_at":"2026-05-30T01:02:34.527742+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TOI Q3 revenue up 22% to $99.9M; net loss narrows to $16.1M, adjusted EBITDA -$8.2M","bullets":["Revenue $99.9M (+21.8% YoY), driven by dispensary revenue surge of 79.9%.","Gross profit $14.4M (-10.1% YoY); SG&A reduced 6% to $26.6M.","Net loss $16.1M ($0.18 EPS) vs $17.4M loss in Q3 2023.","Adjusted EBITDA -$8.2M vs -$5.3M in prior year period.","Board completed strategic review; elected to continue current plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001799191-24-000028","json":"https://secwatch.observer/filing/0001799191-24-000028.json","markdown":"https://secwatch.observer/filing/0001799191-24-000028.md","text":"https://secwatch.observer/filing/0001799191-24-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000179919124000028/0001799191-24-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000179919124000028/toi-20241113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:02:34.527742+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}